282 related articles for article (PubMed ID: 8756720)
1. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates.
Zhu C; Bogue MA; Lim DS; Hasty P; Roth DB
Cell; 1996 Aug; 86(3):379-89. PubMed ID: 8756720
[TBL] [Abstract][Full Text] [Related]
2. V(D)J recombination in Ku86-deficient mice: distinct effects on coding, signal, and hybrid joint formation.
Bogue MA; Wang C; Zhu C; Roth DB
Immunity; 1997 Jul; 7(1):37-47. PubMed ID: 9252118
[TBL] [Abstract][Full Text] [Related]
3. Ku86 is not required for protection of signal ends or for formation of nonstandard V(D)J recombination products.
Han JO; Steen SB; Roth DB
Mol Cell Biol; 1997 Apr; 17(4):2226-34. PubMed ID: 9121473
[TBL] [Abstract][Full Text] [Related]
4. Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation.
Bogue MA; Jhappan C; Roth DB
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15559-64. PubMed ID: 9861008
[TBL] [Abstract][Full Text] [Related]
5. Signal joint formation is inhibited in murine scid preB cells and fibroblasts in substrates with homopolymeric coding ends.
Sun T; Ezekiel UR; Erskine L; Agulo R; Bozek G; Roth D; Storb U
Mol Immunol; 1999 Jun; 36(8):551-8. PubMed ID: 10475610
[TBL] [Abstract][Full Text] [Related]
6. Restoration of X-ray and etoposide resistance, Ku-end binding activity and V(D) J recombination to the Chinese hamster sxi-3 mutant by a hamster Ku86 cDNA.
He DM; Lee SE; Hendrickson EA
Mutat Res; 1996 May; 363(1):43-56. PubMed ID: 8632777
[TBL] [Abstract][Full Text] [Related]
7. Double-strand break repair in Ku86- and XRCC4-deficient cells.
Kabotyanski EB; Gomelsky L; Han JO; Stamato TD; Roth DB
Nucleic Acids Res; 1998 Dec; 26(23):5333-42. PubMed ID: 9826756
[TBL] [Abstract][Full Text] [Related]
8. A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination/repair deficiency.
Nicolas N; Moshous D; Cavazzana-Calvo M; Papadopoulo D; de Chasseval R; Le Deist F; Fischer A; de Villartay JP
J Exp Med; 1998 Aug; 188(4):627-34. PubMed ID: 9705945
[TBL] [Abstract][Full Text] [Related]
9. Protein-protein and protein-DNA interaction regions within the DNA end-binding protein Ku70-Ku86.
Wu X; Lieber MR
Mol Cell Biol; 1996 Sep; 16(9):5186-93. PubMed ID: 8756676
[TBL] [Abstract][Full Text] [Related]
10. Growth retardation and leaky SCID phenotype of Ku70-deficient mice.
Gu Y; Seidl KJ; Rathbun GA; Zhu C; Manis JP; van der Stoep N; Davidson L; Cheng HL; Sekiguchi JM; Frank K; Stanhope-Baker P; Schlissel MS; Roth DB; Alt FW
Immunity; 1997 Nov; 7(5):653-65. PubMed ID: 9390689
[TBL] [Abstract][Full Text] [Related]
11. Ku80-deficient cells exhibit excess degradation of extrachromosomal DNA.
Liang F; Jasin M
J Biol Chem; 1996 Jun; 271(24):14405-11. PubMed ID: 8662903
[TBL] [Abstract][Full Text] [Related]
12. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo.
Ouyang H; Nussenzweig A; Kurimasa A; Soares VC; Li X; Cordon-Cardo C; Li Wh; Cheong N; Nussenzweig M; Iliakis G; Chen DJ; Li GC
J Exp Med; 1997 Sep; 186(6):921-9. PubMed ID: 9294146
[TBL] [Abstract][Full Text] [Related]
13. Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants.
Errami A; Smider V; Rathmell WK; He DM; Hendrickson EA; Zdzienicka MZ; Chu G
Mol Cell Biol; 1996 Apr; 16(4):1519-26. PubMed ID: 8657125
[TBL] [Abstract][Full Text] [Related]
14. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination.
Gao Y; Chaudhuri J; Zhu C; Davidson L; Weaver DT; Alt FW
Immunity; 1998 Sep; 9(3):367-76. PubMed ID: 9768756
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.
Muñoz P; Zdzienicka MZ; Blanchard JM; Piette J
Mol Cell Biol; 1998 Oct; 18(10):5797-808. PubMed ID: 9742097
[TBL] [Abstract][Full Text] [Related]
16. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein.
Muller C; Dusseau C; Calsou P; Salles B
Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022
[TBL] [Abstract][Full Text] [Related]
17. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells.
Verkaik NS; Esveldt-van Lange RE; van Heemst D; Brüggenwirth HT; Hoeijmakers JH; Zdzienicka MZ; van Gent DC
Eur J Immunol; 2002 Mar; 32(3):701-9. PubMed ID: 11870614
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination.
Nussenzweig A; Chen C; da Costa Soares V; Sanchez M; Sokol K; Nussenzweig MC; Li GC
Nature; 1996 Aug; 382(6591):551-5. PubMed ID: 8700231
[TBL] [Abstract][Full Text] [Related]
19. Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.
Lew S; Franco D; Chang Y
Mol Cell Biol; 2000 Oct; 20(19):7170-7. PubMed ID: 10982833
[TBL] [Abstract][Full Text] [Related]
20. The end-joining reaction in V(D)J recombination.
Smider V; Chu G
Semin Immunol; 1997 Jun; 9(3):189-97. PubMed ID: 9200330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
